World News

First-ever postpartum depression pill, Zurzuvae, approved by FDA on August 4, 2023 at 11:36 pm

Published

on

Of the 196 patients who completed the 45-day clinical trial, women who took zuranolone saw “statistically significant improvements” by day 15.

     

​ Of the 196 patients who completed the 45-day clinical trial, women who took zuranolone saw “statistically significant improvements” by day 15.
      

Advertisement
Author:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version